Drug Interaction Report

Metronidazole Injection and Fosphenytoin: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Fosphenytoin

Cerebyx
+

Metronidazole Injection

Flagyl Flagyl® I.V. Flagyl® I.V. RTU® Likmez MetroCream MetroGel MetroLotion Noritate
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 242 documented Metronidazole Injection interactions, 214 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
delayed
Evidence
theoretical
Severity
Major

What happens

An increased risk of fosphenytoin toxicity, reduced metroNIDAZOLE exposure and an increased risk of QT interval prolongation

Interaction Deep Dive

Coadministration of metroNIDAZOLE and drugs that induce microsomal liver enzymes, such as fosphenytoin (prodrug of phenytoin), may accelerate the elimination of metroNIDAZOLE, resulting in reduced exposure of metroNIDAZOLE. Monitor fosphenytoin concentrations during treatment with metroNIDAZOLE. Concomitant use may also cause additive QT interval prolongation1.

Why it happens (mechanism)

Inhibition of fosphenytoin metabolism; induction of CYP450 liver enzymes-mediated metabolism of metroNIDAZOLE; additive QT interval prolongation

Literature reports

3 reports — tap to read

a) Concomitant administration of oral metroNIDAZOLE and IV phenytoin was reported to result in prolongation of the half-life and reduction in the clearance of phenytoin. In this study, phenytoin 300 mg IV was given to volunteers who had been receiving oral metroNIDAZOLE 250 mg 3 times daily for 4 days. The total clearance of phenytoin was reduced from 24 to 20 mL/min with combined therapy, whereas the half-life was increased from 16 to 23 hours. It is speculated that effects on clearance are related to impairment of aromatic hydroxylation of phenytoin by metroNIDAZOLE. The kinetics of oral ALPRAZolam (metabolized by aliphatic hydroxylation) and intravenous LORazepam (metabolized by glucuronide conjugation) were unimpaired with concurrent metroNIDAZOLE in this study. As previous reports have indicated that metroNIDAZOLE can impair the clearance of warfarin (metabolized by aliphatic hydroxylation), it is speculated that there is no apparent way to predict which drugs will be influenced by metroNIDAZOLE administration, despite its capacity to impair the clearance of certain oxidatively metabolized drugs 2.

b) In a pharmacokinetic study in healthy subjects, a single oral dose of phenytoin 300 mg was administered before and after 5 days of metroNIDAZOLE 400 mg twice daily. There were no changes in phenytoin half-life, volume of distribution, or elimination 3.

c) MetroNIDAZOLE can cause QT prolongation 45 and has caused torsades de pointes with concomitant amiodarone administration 6. Susceptible patients may require ECG monitoring 4 and avoidance of medications known to cause QT prolongation 45.

Common questions

Can I take Metronidazole Injection and Fosphenytoin together?

An increased risk of fosphenytoin toxicity, reduced metroNIDAZOLE exposure and an increased risk of QT interval prolongation Always confirm with your pharmacist or prescriber before making any change.

How serious is the Metronidazole Injection and Fosphenytoin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Metronidazole Injection or Fosphenytoin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (6)

  1. Product Information: PYLERA(R) oral capsules, bismuth subcitrate potassium, metronidazole, tetracycline HCl oral capsules. H2-Pharma, LLC (per FDA), Montgomery, AL, 2025. DailyMed
  2. Blyden GT, Scavone JM, & Greenblatt DJ: Metronidazole impairs clearance of phenytoin but not alprazolam or lorazepam. J Clin Pharmacol 1988; 28:240-245.
  3. Jensen JC & Gugler R: Interaction between metronidazole and drugs eliminated by oxidative metabolism. Clin Pharmacol Ther 1985; 37:407-410. PubMed
  4. Altin C, Kanyilmaz S, Baysal S, et al: QT interval prolongation due to metronidazole administration. Anadolu Kardiyol Derg 2011; 11(5):468-469. PubMed
  5. Cohen O, Saar N, Swartzon M, et al: First report of metronidazole-induced QT interval prolongation. Int J Antimicrob Agents 2008; 31(2):180-181. DOI
  6. Kounas SP, Letsas KP, Sideris A, et al: QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Pacing Clin Electrophysiol 2005; 28:472-473. PubMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.